VP45.22: Lung ultrasound is not a useful screening tool for SARS‐CoV2 in pregnant women

Documenti analoghi

• VP45.27: Lung ultrasound in pregnant women with COVID‐19 as the unique lung imaging modality
  di: Youssef, A., et al.
  Pubblicazione: (2020)
• VP45.21: Clinical correlation of severe and non‐severe infection by SARS‐CoV2 in pregnant women
  di: Torres‐Torres, J., et al.
  Pubblicazione: (2020)
• VP45.31: Prevalence of SARS‐CoV2 in asymptomatic patients
  di: Rodriguez, C., et al.
  Pubblicazione: (2020)
• VP45.26: Pregnant patient infected by SARS‐CoV2: management protocol in the delivery room of the General Hospital of Mexico
  di: Torres‐Torres, J., et al.
  Pubblicazione: (2020)
• VP45.29: Effectiveness of low‐dose hydroxychloroquine versus placebo for the prevention of severe pneumonia in pregnant women with SARS‐CoV2 infection: PROTOCOL for a randomised controlled trial (HYPREG trial)
  di: Torres‐Torres, J., et al.
  Pubblicazione: (2020)